This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of novel therapeutic agents. Its unique structure, featuring a spirocyclic system and fluorine substitution, makes it valuable for targeting specific biological pathways, particularly in the development of drugs for central nervous system (CNS) disorders. Researchers explore its potential in modulating receptors or enzymes associated with neurological conditions, such as anxiety, depression, or neurodegenerative diseases. Additionally, its incorporation into drug candidates aims to enhance pharmacokinetic properties, including bioavailability and metabolic stability, thereby improving therapeutic efficacy.